UnitedHealth Group’s Robust Q2 Performance: Oppenheimer’s View On Profit Increase And Revised FY23 Guidance

Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating on UnitedHealth Group (NYSE:UNH), with a price target of $610.

The company reported nearly $5.5 billion in Q2, up 8% Y/Y in profits as its health insurance plans and Optum medical provider businesses grew by “double-digit” percentages despite rising costs.